nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—Procaine—Probenecid—gout	0.186	0.587	CrCrCtD
Metoclopramide—systemic scleroderma—Colchicine—gout	0.146	0.347	CpDpCtD
Metoclopramide—Procainamide—Probenecid—gout	0.13	0.413	CrCrCtD
Metoclopramide—CYP11B2—Hydrocortisone—gout	0.123	0.606	CbGbCtD
Metoclopramide—prostate cancer—Hydrocortisone—gout	0.0955	0.227	CpDpCtD
Metoclopramide—CYP11B1—Hydrocortisone—gout	0.0802	0.394	CbGbCtD
Metoclopramide—migraine—Indomethacin—gout	0.0759	0.18	CpDpCtD
Metoclopramide—migraine—Naproxen—gout	0.0694	0.165	CpDpCtD
Metoclopramide—migraine—Prednisone—gout	0.0339	0.0806	CpDpCtD
Metoclopramide—CYP11B2—Glucocorticoid biosynthesis—POMC—gout	0.00097	0.0952	CbGpPWpGaD
Metoclopramide—CYP11B1—Glucocorticoid biosynthesis—POMC—gout	0.000836	0.0821	CbGpPWpGaD
Metoclopramide—CYP17A1—Glucocorticoid biosynthesis—POMC—gout	0.000782	0.0767	CbGpPWpGaD
Metoclopramide—HTR3A—Ion channel transport—SLC17A3—gout	0.000662	0.065	CbGpPWpGaD
Metoclopramide—CYP17A1—Androgen biosynthesis—POMC—gout	0.000606	0.0595	CbGpPWpGaD
Metoclopramide—Rash maculo-papular—Allopurinol—gout	0.000419	0.00846	CcSEcCtD
Metoclopramide—CYP11B2—Endogenous sterols—POMC—gout	0.000417	0.0409	CbGpPWpGaD
Metoclopramide—Gynaecomastia—Allopurinol—gout	0.000412	0.00832	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Indomethacin—gout	0.000407	0.00821	CcSEcCtD
Metoclopramide—Wheezing—Naproxen—gout	0.000391	0.00789	CcSEcCtD
Metoclopramide—Urinary incontinence—Naproxen—gout	0.000389	0.00784	CcSEcCtD
Metoclopramide—Renal impairment—Indomethacin—gout	0.000387	0.00782	CcSEcCtD
Metoclopramide—Menstruation irregular—Prednisolone—gout	0.000386	0.00779	CcSEcCtD
Metoclopramide—Menstruation irregular—Hydrocortisone—gout	0.000377	0.00761	CcSEcCtD
Metoclopramide—CYP11B1—Endogenous sterols—POMC—gout	0.000359	0.0353	CbGpPWpGaD
Metoclopramide—Menstruation irregular—Methylprednisolone—gout	0.000354	0.00715	CcSEcCtD
Metoclopramide—Renal impairment—Allopurinol—gout	0.000352	0.0071	CcSEcCtD
Metoclopramide—CYP17A1—Endogenous sterols—POMC—gout	0.000336	0.033	CbGpPWpGaD
Metoclopramide—Cardiac failure congestive—Naproxen—gout	0.000322	0.0065	CcSEcCtD
Metoclopramide—Asthma—Indomethacin—gout	0.000319	0.00643	CcSEcCtD
Metoclopramide—Urticaria—Probenecid—gout	0.000316	0.00638	CcSEcCtD
Metoclopramide—Body temperature increased—Probenecid—gout	0.000315	0.00635	CcSEcCtD
Metoclopramide—Neutropenia—Colchicine—gout	0.000314	0.00633	CcSEcCtD
Metoclopramide—CYP11B2—Metabolism of steroid hormones and vitamin D—POMC—gout	0.000312	0.0306	CbGpPWpGaD
Metoclopramide—Visual disturbance—Naproxen—gout	0.000308	0.00622	CcSEcCtD
Metoclopramide—Renal impairment—Naproxen—gout	0.000307	0.0062	CcSEcCtD
Metoclopramide—Suicidal ideation—Hydrocortisone—gout	0.000298	0.00601	CcSEcCtD
Metoclopramide—Pollakiuria—Indomethacin—gout	0.000294	0.00594	CcSEcCtD
Metoclopramide—Hypersensitivity—Probenecid—gout	0.000293	0.00592	CcSEcCtD
Metoclopramide—Asthma—Allopurinol—gout	0.000289	0.00584	CcSEcCtD
Metoclopramide—Mania—Hydrocortisone—gout	0.000287	0.00579	CcSEcCtD
Metoclopramide—Bronchospasm—Allopurinol—gout	0.000284	0.00574	CcSEcCtD
Metoclopramide—Drowsiness—Indomethacin—gout	0.000284	0.00574	CcSEcCtD
Metoclopramide—Depression—Indomethacin—gout	0.000283	0.00572	CcSEcCtD
Metoclopramide—Menstruation irregular—Prednisone—gout	0.000281	0.00566	CcSEcCtD
Metoclopramide—Suicidal ideation—Methylprednisolone—gout	0.00028	0.00564	CcSEcCtD
Metoclopramide—Agranulocytosis—Colchicine—gout	0.000279	0.00563	CcSEcCtD
Metoclopramide—Jaundice—Indomethacin—gout	0.000277	0.00559	CcSEcCtD
Metoclopramide—Neutropenia—Allopurinol—gout	0.00027	0.00546	CcSEcCtD
Metoclopramide—Mania—Methylprednisolone—gout	0.00027	0.00544	CcSEcCtD
Metoclopramide—CYP11B1—Metabolism of steroid hormones and vitamin D—POMC—gout	0.000269	0.0264	CbGpPWpGaD
Metoclopramide—Erectile dysfunction—Allopurinol—gout	0.000266	0.00538	CcSEcCtD
Metoclopramide—Agranulocytosis—Indomethacin—gout	0.000265	0.00535	CcSEcCtD
Metoclopramide—Dizziness—Probenecid—gout	0.000263	0.00531	CcSEcCtD
Metoclopramide—Bradycardia—Indomethacin—gout	0.00026	0.00524	CcSEcCtD
Metoclopramide—Drowsiness—Allopurinol—gout	0.000258	0.0052	CcSEcCtD
Metoclopramide—Depression—Allopurinol—gout	0.000257	0.00519	CcSEcCtD
Metoclopramide—Asthma—Naproxen—gout	0.000252	0.0051	CcSEcCtD
Metoclopramide—CYP17A1—Metabolism of steroid hormones and vitamin D—POMC—gout	0.000252	0.0247	CbGpPWpGaD
Metoclopramide—Jaundice—Allopurinol—gout	0.000251	0.00507	CcSEcCtD
Metoclopramide—Dermatitis—Probenecid—gout	0.000251	0.00506	CcSEcCtD
Metoclopramide—Headache—Probenecid—gout	0.000249	0.00503	CcSEcCtD
Metoclopramide—Agranulocytosis—Allopurinol—gout	0.000241	0.00486	CcSEcCtD
Metoclopramide—Amenorrhoea—Hydrocortisone—gout	0.000238	0.0048	CcSEcCtD
Metoclopramide—Flushing—Indomethacin—gout	0.000237	0.00478	CcSEcCtD
Metoclopramide—Nausea—Probenecid—gout	0.000236	0.00477	CcSEcCtD
Metoclopramide—Bradycardia—Allopurinol—gout	0.000236	0.00476	CcSEcCtD
Metoclopramide—Pollakiuria—Naproxen—gout	0.000233	0.00471	CcSEcCtD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—SLC17A3—gout	0.00023	0.0226	CbGpPWpGaD
Metoclopramide—Drowsiness—Naproxen—gout	0.000225	0.00454	CcSEcCtD
Metoclopramide—Muscle spasms—Colchicine—gout	0.000225	0.00454	CcSEcCtD
Metoclopramide—Depression—Naproxen—gout	0.000224	0.00453	CcSEcCtD
Metoclopramide—Amenorrhoea—Methylprednisolone—gout	0.000223	0.00451	CcSEcCtD
Metoclopramide—Visual impairment—Allopurinol—gout	0.000223	0.0045	CcSEcCtD
Metoclopramide—Suicidal ideation—Prednisone—gout	0.000221	0.00447	CcSEcCtD
Metoclopramide—Sunitinib—ABCG2—gout	0.000221	1	CrCbGaD
Metoclopramide—Jaundice—Naproxen—gout	0.000219	0.00443	CcSEcCtD
Metoclopramide—Nervousness—Indomethacin—gout	0.000216	0.00435	CcSEcCtD
Metoclopramide—Flushing—Allopurinol—gout	0.000215	0.00434	CcSEcCtD
Metoclopramide—Angioedema—Colchicine—gout	0.000214	0.00431	CcSEcCtD
Metoclopramide—Mania—Prednisone—gout	0.000214	0.00431	CcSEcCtD
Metoclopramide—Agranulocytosis—Naproxen—gout	0.00021	0.00424	CcSEcCtD
Metoclopramide—Leukopenia—Colchicine—gout	0.000209	0.00422	CcSEcCtD
Metoclopramide—Angioedema—Indomethacin—gout	0.000203	0.0041	CcSEcCtD
Metoclopramide—Fluid retention—Prednisolone—gout	0.000203	0.0041	CcSEcCtD
Metoclopramide—Hallucination—Naproxen—gout	0.000201	0.00406	CcSEcCtD
Metoclopramide—Leukopenia—Indomethacin—gout	0.000199	0.00401	CcSEcCtD
Metoclopramide—Fluid retention—Hydrocortisone—gout	0.000198	0.004	CcSEcCtD
Metoclopramide—Palpitations—Indomethacin—gout	0.000196	0.00396	CcSEcCtD
Metoclopramide—Visual impairment—Naproxen—gout	0.000195	0.00393	CcSEcCtD
Metoclopramide—CYP11B2—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000193	0.019	CbGpPWpGaD
Metoclopramide—Convulsion—Indomethacin—gout	0.000192	0.00388	CcSEcCtD
Metoclopramide—Hypertension—Indomethacin—gout	0.000192	0.00387	CcSEcCtD
Metoclopramide—Rash maculo-papular—Hydrocortisone—gout	0.00019	0.00383	CcSEcCtD
Metoclopramide—Tremor—Allopurinol—gout	0.000189	0.00381	CcSEcCtD
Metoclopramide—Anxiety—Indomethacin—gout	0.000188	0.0038	CcSEcCtD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—SLC22A11—gout	0.000188	0.0184	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—SLC17A1—gout	0.000188	0.0184	CbGpPWpGaD
Metoclopramide—Fluid retention—Methylprednisolone—gout	0.000186	0.00376	CcSEcCtD
Metoclopramide—Agitation—Allopurinol—gout	0.000185	0.00374	CcSEcCtD
Metoclopramide—Angioedema—Allopurinol—gout	0.000184	0.00372	CcSEcCtD
Metoclopramide—Confusional state—Indomethacin—gout	0.000183	0.00369	CcSEcCtD
Metoclopramide—Oedema—Indomethacin—gout	0.000181	0.00366	CcSEcCtD
Metoclopramide—Delirium—Prednisone—gout	0.000181	0.00364	CcSEcCtD
Metoclopramide—Leukopenia—Allopurinol—gout	0.00018	0.00364	CcSEcCtD
Metoclopramide—Hypotension—Colchicine—gout	0.000178	0.0036	CcSEcCtD
Metoclopramide—Tachycardia—Indomethacin—gout	0.000177	0.00357	CcSEcCtD
Metoclopramide—Amenorrhoea—Prednisone—gout	0.000177	0.00357	CcSEcCtD
Metoclopramide—Convulsion—Allopurinol—gout	0.000175	0.00352	CcSEcCtD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—IL1RN—gout	0.000174	0.0171	CbGpPWpGaD
Metoclopramide—Hypertension—Allopurinol—gout	0.000174	0.00351	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisolone—gout	0.000171	0.00345	CcSEcCtD
Metoclopramide—Nervousness—Naproxen—gout	0.000171	0.00345	CcSEcCtD
Metoclopramide—Hypotension—Indomethacin—gout	0.000169	0.00342	CcSEcCtD
Metoclopramide—Muscle spasms—Naproxen—gout	0.000169	0.00341	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Hydrocortisone—gout	0.000167	0.00337	CcSEcCtD
Metoclopramide—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000167	0.0164	CbGpPWpGaD
Metoclopramide—Confusional state—Allopurinol—gout	0.000166	0.00335	CcSEcCtD
Metoclopramide—Tremor—Naproxen—gout	0.000165	0.00333	CcSEcCtD
Metoclopramide—Oedema—Allopurinol—gout	0.000164	0.00332	CcSEcCtD
Metoclopramide—Fatigue—Colchicine—gout	0.000164	0.00332	CcSEcCtD
Metoclopramide—Insomnia—Indomethacin—gout	0.000164	0.00331	CcSEcCtD
Metoclopramide—Visual disturbance—Prednisolone—gout	0.000164	0.0033	CcSEcCtD
Metoclopramide—Dyspnoea—Indomethacin—gout	0.000162	0.00326	CcSEcCtD
Metoclopramide—Somnolence—Indomethacin—gout	0.000161	0.00325	CcSEcCtD
Metoclopramide—Angioedema—Naproxen—gout	0.000161	0.00324	CcSEcCtD
Metoclopramide—Leukopenia—Naproxen—gout	0.000157	0.00318	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Methylprednisolone—gout	0.000157	0.00317	CcSEcCtD
Metoclopramide—CYP11B2—Phase 1 - Functionalization of compounds—POMC—gout	0.000157	0.0154	CbGpPWpGaD
Metoclopramide—Fatigue—Indomethacin—gout	0.000156	0.00315	CcSEcCtD
Metoclopramide—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000156	0.0153	CbGpPWpGaD
Metoclopramide—Palpitations—Naproxen—gout	0.000155	0.00314	CcSEcCtD
Metoclopramide—Hypotension—Allopurinol—gout	0.000154	0.0031	CcSEcCtD
Metoclopramide—Convulsion—Naproxen—gout	0.000152	0.00308	CcSEcCtD
Metoclopramide—Hypertension—Naproxen—gout	0.000152	0.00307	CcSEcCtD
Metoclopramide—Urticaria—Colchicine—gout	0.000152	0.00306	CcSEcCtD
Metoclopramide—Feeling abnormal—Indomethacin—gout	0.000149	0.00301	CcSEcCtD
Metoclopramide—Anxiety—Naproxen—gout	0.000149	0.00301	CcSEcCtD
Metoclopramide—Insomnia—Allopurinol—gout	0.000149	0.003	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisolone—gout	0.000148	0.00298	CcSEcCtD
Metoclopramide—Fluid retention—Prednisone—gout	0.000147	0.00298	CcSEcCtD
Metoclopramide—Somnolence—Allopurinol—gout	0.000146	0.00295	CcSEcCtD
Metoclopramide—Confusional state—Naproxen—gout	0.000145	0.00292	CcSEcCtD
Metoclopramide—HTR4—G alpha (s) signalling events—POMC—gout	0.000145	0.0142	CbGpPWpGaD
Metoclopramide—Cardiac arrest—Hydrocortisone—gout	0.000144	0.00291	CcSEcCtD
Metoclopramide—Urticaria—Indomethacin—gout	0.000144	0.00291	CcSEcCtD
Metoclopramide—Oedema—Naproxen—gout	0.000144	0.0029	CcSEcCtD
Metoclopramide—Body temperature increased—Indomethacin—gout	0.000143	0.00289	CcSEcCtD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—SLC22A12—gout	0.000142	0.014	CbGpPWpGaD
Metoclopramide—Hypersensitivity—Colchicine—gout	0.000141	0.00284	CcSEcCtD
Metoclopramide—Tachycardia—Naproxen—gout	0.00014	0.00283	CcSEcCtD
Metoclopramide—Asthenia—Colchicine—gout	0.000137	0.00276	CcSEcCtD
Metoclopramide—Feeling abnormal—Allopurinol—gout	0.000136	0.00274	CcSEcCtD
Metoclopramide—Cardiac arrest—Methylprednisolone—gout	0.000135	0.00273	CcSEcCtD
Metoclopramide—CYP11B1—Phase 1 - Functionalization of compounds—POMC—gout	0.000135	0.0133	CbGpPWpGaD
Metoclopramide—Hypotension—Naproxen—gout	0.000134	0.00271	CcSEcCtD
Metoclopramide—Hypersensitivity—Indomethacin—gout	0.000134	0.0027	CcSEcCtD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—SLC2A9—gout	0.000132	0.013	CbGpPWpGaD
Metoclopramide—Urticaria—Allopurinol—gout	0.000131	0.00264	CcSEcCtD
Metoclopramide—Diarrhoea—Colchicine—gout	0.000131	0.00263	CcSEcCtD
Metoclopramide—Asthenia—Indomethacin—gout	0.00013	0.00262	CcSEcCtD
Metoclopramide—Body temperature increased—Allopurinol—gout	0.00013	0.00262	CcSEcCtD
Metoclopramide—Insomnia—Naproxen—gout	0.00013	0.00262	CcSEcCtD
Metoclopramide—Dyspnoea—Naproxen—gout	0.000128	0.00258	CcSEcCtD
Metoclopramide—Somnolence—Naproxen—gout	0.000128	0.00258	CcSEcCtD
Metoclopramide—CYP17A1—Phase 1 - Functionalization of compounds—POMC—gout	0.000126	0.0124	CbGpPWpGaD
Metoclopramide—Cardiac failure congestive—Prednisone—gout	0.000124	0.00251	CcSEcCtD
Metoclopramide—Diarrhoea—Indomethacin—gout	0.000124	0.0025	CcSEcCtD
Metoclopramide—Fatigue—Naproxen—gout	0.000124	0.0025	CcSEcCtD
Metoclopramide—Hypersensitivity—Allopurinol—gout	0.000121	0.00245	CcSEcCtD
Metoclopramide—Bronchospasm—Methylprednisolone—gout	0.000121	0.00244	CcSEcCtD
Metoclopramide—Rash—Colchicine—gout	0.00012	0.00243	CcSEcCtD
Metoclopramide—Dermatitis—Colchicine—gout	0.00012	0.00243	CcSEcCtD
Metoclopramide—Dizziness—Indomethacin—gout	0.00012	0.00242	CcSEcCtD
Metoclopramide—Headache—Colchicine—gout	0.000119	0.00241	CcSEcCtD
Metoclopramide—CYP11B1—Corticotropin-releasing hormone—POMC—gout	0.000118	0.0116	CbGpPWpGaD
Metoclopramide—Feeling abnormal—Naproxen—gout	0.000118	0.00239	CcSEcCtD
Metoclopramide—Asthenia—Allopurinol—gout	0.000118	0.00238	CcSEcCtD
Metoclopramide—Rash—Indomethacin—gout	0.000114	0.00231	CcSEcCtD
Metoclopramide—Dermatitis—Indomethacin—gout	0.000114	0.0023	CcSEcCtD
Metoclopramide—Urticaria—Naproxen—gout	0.000114	0.0023	CcSEcCtD
Metoclopramide—Headache—Indomethacin—gout	0.000114	0.00229	CcSEcCtD
Metoclopramide—Body temperature increased—Naproxen—gout	0.000114	0.00229	CcSEcCtD
Metoclopramide—Nausea—Colchicine—gout	0.000113	0.00229	CcSEcCtD
Metoclopramide—Diarrhoea—Allopurinol—gout	0.000113	0.00227	CcSEcCtD
Metoclopramide—CYP11B2—Metabolism—BCKDHA—gout	0.00011	0.0108	CbGpPWpGaD
Metoclopramide—Bradycardia—Prednisolone—gout	0.000109	0.00221	CcSEcCtD
Metoclopramide—Dizziness—Allopurinol—gout	0.000109	0.0022	CcSEcCtD
Metoclopramide—Nausea—Indomethacin—gout	0.000108	0.00217	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisone—gout	0.000107	0.00216	CcSEcCtD
Metoclopramide—Bradycardia—Hydrocortisone—gout	0.000107	0.00215	CcSEcCtD
Metoclopramide—Hypersensitivity—Naproxen—gout	0.000106	0.00214	CcSEcCtD
Metoclopramide—Hallucination—Hydrocortisone—gout	0.000104	0.00211	CcSEcCtD
Metoclopramide—Rash—Allopurinol—gout	0.000104	0.00209	CcSEcCtD
Metoclopramide—Dermatitis—Allopurinol—gout	0.000104	0.00209	CcSEcCtD
Metoclopramide—Visual impairment—Prednisolone—gout	0.000103	0.00209	CcSEcCtD
Metoclopramide—Headache—Allopurinol—gout	0.000103	0.00208	CcSEcCtD
Metoclopramide—Asthenia—Naproxen—gout	0.000103	0.00208	CcSEcCtD
Metoclopramide—Bradycardia—Methylprednisolone—gout	0.0001	0.00202	CcSEcCtD
Metoclopramide—Diarrhoea—Naproxen—gout	9.82e-05	0.00198	CcSEcCtD
Metoclopramide—Hallucination—Methylprednisolone—gout	9.8e-05	0.00198	CcSEcCtD
Metoclopramide—Nausea—Allopurinol—gout	9.77e-05	0.00197	CcSEcCtD
Metoclopramide—CYP11B1—Metabolism—BCKDHA—gout	9.5e-05	0.00933	CbGpPWpGaD
Metoclopramide—Dizziness—Naproxen—gout	9.49e-05	0.00192	CcSEcCtD
Metoclopramide—Visual impairment—Methylprednisolone—gout	9.49e-05	0.00192	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—gout	9.11e-05	0.00184	CcSEcCtD
Metoclopramide—Rash—Naproxen—gout	9.05e-05	0.00183	CcSEcCtD
Metoclopramide—Dermatitis—Naproxen—gout	9.04e-05	0.00183	CcSEcCtD
Metoclopramide—Headache—Naproxen—gout	9e-05	0.00182	CcSEcCtD
Metoclopramide—CYP11B2—Metabolism—PRPS2—gout	8.99e-05	0.00883	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—HPRT1—gout	8.99e-05	0.00883	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PRPS1—gout	8.99e-05	0.00883	CbGpPWpGaD
Metoclopramide—Erectile dysfunction—Prednisone—gout	8.97e-05	0.00181	CcSEcCtD
Metoclopramide—CYP17A1—Metabolism—BCKDHA—gout	8.89e-05	0.00873	CbGpPWpGaD
Metoclopramide—Depression—Prednisone—gout	8.66e-05	0.00175	CcSEcCtD
Metoclopramide—Angioedema—Prednisolone—gout	8.54e-05	0.00172	CcSEcCtD
Metoclopramide—Nausea—Naproxen—gout	8.53e-05	0.00172	CcSEcCtD
Metoclopramide—Angioedema—Hydrocortisone—gout	8.34e-05	0.00168	CcSEcCtD
Metoclopramide—CYP11B2—Biological oxidations—POMC—gout	8.33e-05	0.00818	CbGpPWpGaD
Metoclopramide—Convulsion—Prednisolone—gout	8.09e-05	0.00163	CcSEcCtD
Metoclopramide—Hypertension—Prednisolone—gout	8.07e-05	0.00163	CcSEcCtD
Metoclopramide—Bradycardia—Prednisone—gout	7.94e-05	0.0016	CcSEcCtD
Metoclopramide—Convulsion—Hydrocortisone—gout	7.91e-05	0.0016	CcSEcCtD
Metoclopramide—Hypertension—Hydrocortisone—gout	7.88e-05	0.00159	CcSEcCtD
Metoclopramide—Angioedema—Methylprednisolone—gout	7.83e-05	0.00158	CcSEcCtD
Metoclopramide—Hallucination—Prednisone—gout	7.76e-05	0.00157	CcSEcCtD
Metoclopramide—CYP11B1—Metabolism—PRPS1—gout	7.75e-05	0.00761	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—HPRT1—gout	7.75e-05	0.00761	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PRPS2—gout	7.75e-05	0.00761	CbGpPWpGaD
Metoclopramide—Anxiety—Hydrocortisone—gout	7.74e-05	0.00156	CcSEcCtD
Metoclopramide—Oedema—Prednisolone—gout	7.63e-05	0.00154	CcSEcCtD
Metoclopramide—Oedema—Hydrocortisone—gout	7.45e-05	0.0015	CcSEcCtD
Metoclopramide—Tachycardia—Prednisolone—gout	7.44e-05	0.0015	CcSEcCtD
Metoclopramide—Convulsion—Methylprednisolone—gout	7.43e-05	0.0015	CcSEcCtD
Metoclopramide—Hypertension—Methylprednisolone—gout	7.4e-05	0.00149	CcSEcCtD
Metoclopramide—Anxiety—Methylprednisolone—gout	7.27e-05	0.00147	CcSEcCtD
Metoclopramide—Tachycardia—Hydrocortisone—gout	7.27e-05	0.00147	CcSEcCtD
Metoclopramide—CYP17A1—Metabolism—PRPS1—gout	7.24e-05	0.00711	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PRPS2—gout	7.24e-05	0.00711	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—HPRT1—gout	7.24e-05	0.00711	CbGpPWpGaD
Metoclopramide—Flushing—Prednisone—gout	7.24e-05	0.00146	CcSEcCtD
Metoclopramide—CYP11B1—Biological oxidations—POMC—gout	7.18e-05	0.00705	CbGpPWpGaD
Metoclopramide—Confusional state—Methylprednisolone—gout	7.05e-05	0.00142	CcSEcCtD
Metoclopramide—Hypotension—Hydrocortisone—gout	6.96e-05	0.0014	CcSEcCtD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—ABCG2—gout	6.95e-05	0.00683	CbGpPWpGaD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—POMC—gout	6.9e-05	0.00678	CbGpPWpGaD
Metoclopramide—Insomnia—Prednisolone—gout	6.9e-05	0.00139	CcSEcCtD
Metoclopramide—Tachycardia—Methylprednisolone—gout	6.83e-05	0.00138	CcSEcCtD
Metoclopramide—Insomnia—Hydrocortisone—gout	6.74e-05	0.00136	CcSEcCtD
Metoclopramide—CYP17A1—Biological oxidations—POMC—gout	6.71e-05	0.00659	CbGpPWpGaD
Metoclopramide—Hypotension—Methylprednisolone—gout	6.54e-05	0.00132	CcSEcCtD
Metoclopramide—Fatigue—Hydrocortisone—gout	6.42e-05	0.0013	CcSEcCtD
Metoclopramide—Insomnia—Methylprednisolone—gout	6.33e-05	0.00128	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisolone—gout	6.28e-05	0.00127	CcSEcCtD
Metoclopramide—Agitation—Prednisone—gout	6.24e-05	0.00126	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—gout	6.2e-05	0.00125	CcSEcCtD
Metoclopramide—Feeling abnormal—Hydrocortisone—gout	6.14e-05	0.00124	CcSEcCtD
Metoclopramide—Urticaria—Prednisolone—gout	6.06e-05	0.00122	CcSEcCtD
Metoclopramide—Fatigue—Methylprednisolone—gout	6.03e-05	0.00122	CcSEcCtD
Metoclopramide—Urticaria—Hydrocortisone—gout	5.92e-05	0.00119	CcSEcCtD
Metoclopramide—Body temperature increased—Hydrocortisone—gout	5.89e-05	0.00119	CcSEcCtD
Metoclopramide—Convulsion—Prednisone—gout	5.88e-05	0.00119	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—gout	5.86e-05	0.00118	CcSEcCtD
Metoclopramide—Feeling abnormal—Methylprednisolone—gout	5.77e-05	0.00116	CcSEcCtD
Metoclopramide—Anxiety—Prednisone—gout	5.76e-05	0.00116	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisolone—gout	5.62e-05	0.00113	CcSEcCtD
Metoclopramide—Urticaria—Methylprednisolone—gout	5.56e-05	0.00112	CcSEcCtD
Metoclopramide—Oedema—Prednisone—gout	5.54e-05	0.00112	CcSEcCtD
Metoclopramide—Hypersensitivity—Hydrocortisone—gout	5.49e-05	0.00111	CcSEcCtD
Metoclopramide—Tachycardia—Prednisone—gout	5.41e-05	0.00109	CcSEcCtD
Metoclopramide—Asthenia—Hydrocortisone—gout	5.34e-05	0.00108	CcSEcCtD
Metoclopramide—HTR4—GPCR ligand binding—POMC—gout	5.25e-05	0.00516	CbGpPWpGaD
Metoclopramide—Hypersensitivity—Methylprednisolone—gout	5.15e-05	0.00104	CcSEcCtD
Metoclopramide—Diarrhoea—Hydrocortisone—gout	5.1e-05	0.00103	CcSEcCtD
Metoclopramide—Dizziness—Prednisolone—gout	5.04e-05	0.00102	CcSEcCtD
Metoclopramide—Asthenia—Methylprednisolone—gout	5.02e-05	0.00101	CcSEcCtD
Metoclopramide—Insomnia—Prednisone—gout	5.01e-05	0.00101	CcSEcCtD
Metoclopramide—Dizziness—Hydrocortisone—gout	4.92e-05	0.000994	CcSEcCtD
Metoclopramide—Rash—Prednisolone—gout	4.81e-05	0.00097	CcSEcCtD
Metoclopramide—Dermatitis—Prednisolone—gout	4.8e-05	0.00097	CcSEcCtD
Metoclopramide—Diarrhoea—Methylprednisolone—gout	4.79e-05	0.000966	CcSEcCtD
Metoclopramide—Fatigue—Prednisone—gout	4.78e-05	0.000964	CcSEcCtD
Metoclopramide—Headache—Prednisolone—gout	4.78e-05	0.000964	CcSEcCtD
Metoclopramide—Rash—Hydrocortisone—gout	4.7e-05	0.000948	CcSEcCtD
Metoclopramide—Dermatitis—Hydrocortisone—gout	4.69e-05	0.000947	CcSEcCtD
Metoclopramide—Headache—Hydrocortisone—gout	4.67e-05	0.000942	CcSEcCtD
Metoclopramide—Dizziness—Methylprednisolone—gout	4.63e-05	0.000934	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisone—gout	4.57e-05	0.000922	CcSEcCtD
Metoclopramide—Nausea—Prednisolone—gout	4.53e-05	0.000914	CcSEcCtD
Metoclopramide—Nausea—Hydrocortisone—gout	4.42e-05	0.000893	CcSEcCtD
Metoclopramide—Rash—Methylprednisolone—gout	4.41e-05	0.00089	CcSEcCtD
Metoclopramide—Dermatitis—Methylprednisolone—gout	4.41e-05	0.00089	CcSEcCtD
Metoclopramide—Urticaria—Prednisone—gout	4.4e-05	0.000888	CcSEcCtD
Metoclopramide—Headache—Methylprednisolone—gout	4.38e-05	0.000885	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—gout	4.38e-05	0.000884	CcSEcCtD
Metoclopramide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	4.22e-05	0.00414	CbGpPWpGaD
Metoclopramide—Nausea—Methylprednisolone—gout	4.16e-05	0.000839	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisone—gout	4.08e-05	0.000824	CcSEcCtD
Metoclopramide—Asthenia—Prednisone—gout	3.98e-05	0.000802	CcSEcCtD
Metoclopramide—Diarrhoea—Prednisone—gout	3.79e-05	0.000765	CcSEcCtD
Metoclopramide—Dizziness—Prednisone—gout	3.66e-05	0.00074	CcSEcCtD
Metoclopramide—Rash—Prednisone—gout	3.49e-05	0.000705	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—gout	3.49e-05	0.000705	CcSEcCtD
Metoclopramide—Headache—Prednisone—gout	3.47e-05	0.000701	CcSEcCtD
Metoclopramide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	3.42e-05	0.00336	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ABCG2—gout	3.33e-05	0.00327	CbGpPWpGaD
Metoclopramide—Nausea—Prednisone—gout	3.29e-05	0.000664	CcSEcCtD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—POMC—gout	3.2e-05	0.00314	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—POMC—gout	3.17e-05	0.00311	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—POMC—gout	2.97e-05	0.00292	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ABCG2—gout	2.87e-05	0.00282	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—POMC—gout	2.76e-05	0.00271	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—POMC—gout	2.7e-05	0.00265	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ABCG2—gout	2.68e-05	0.00263	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—POMC—gout	2.58e-05	0.00253	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—gout	2.52e-05	0.00247	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—POMC—gout	2.42e-05	0.00238	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—BCKDHA—gout	2.4e-05	0.00236	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PRPS1—gout	1.96e-05	0.00192	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PRPS2—gout	1.96e-05	0.00192	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HPRT1—gout	1.96e-05	0.00192	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—gout	1.93e-05	0.00189	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—POMC—gout	1.92e-05	0.00188	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—gout	1.89e-05	0.00185	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—POMC—gout	1.82e-05	0.00178	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—POMC—gout	1.59e-05	0.00156	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—POMC—gout	1.47e-05	0.00144	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—POMC—gout	1.44e-05	0.00141	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—POMC—gout	1.42e-05	0.0014	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—POMC—gout	1.23e-05	0.00121	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—POMC—gout	1.15e-05	0.00113	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—POMC—gout	1.08e-05	0.00106	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—POMC—gout	9.85e-06	0.000967	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—POMC—gout	8.3e-06	0.000815	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—POMC—gout	8.12e-06	0.000797	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—POMC—gout	7.53e-06	0.00074	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—POMC—gout	7.37e-06	0.000724	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCG2—gout	7.25e-06	0.000712	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—POMC—gout	5.82e-06	0.000571	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—POMC—gout	4.45e-06	0.000437	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—POMC—gout	4.36e-06	0.000428	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—POMC—gout	3.11e-06	0.000305	CbGpPWpGaD
